Thyromimetics for the treatment of fatty liver diseases

Details Thyromimetics for the treatment of fatty liver diseases Thyromimetics for the treatment of fatty liver diseases

A - Human Necessities

61

K

A61K 31/661 (2006.01) A61K 31/662 (2006.01) A61K 31/665 (2006.01) A61P 3/00 (2006.01)

Patent

CA 2606499

The present invention is directed toward the use of thyromimetic compounds that are thyroid receptor ligands, pharmaceutically acceptable salts thereof, and to prodrugs of these compounds for preventing, treating, or ameliorating fatty liver diseases such as steatosis, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis.

L'invention se rapporte à des composés thyromimétiques récepteurs du ligand tyroïdien, à leurs sels pharmaceutiquement acceptables et à des promédicaments de ces composés, utilisés dans la prévention, le traitement ou l'amélioration de maladies hépatiques graisseuses telles que la stéatose, les hépatites graisseuses non alcooliques et la stéato-hépatite non alcoolique.

Affiliated with

Also associated with

Rating

Thyromimetics for the treatment of fatty liver diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thyromimetics for the treatment of fatty liver diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thyromimetics for the treatment of fatty liver diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2091736